1. DNAJC6 mutations disrupt dopamine homeostasis in juvenile parkinsonism-dystonia
- Author
-
Esther Meyer, Christian de Goede, Manju A. Kurian, Sniya Sudhakar, Barbara Csányi, Helen Coutts, Lucia Abela, Simon Heales, Joanne Ng, Sandeep Jayawant, Detelina Grozeva, Karl Rakshi, Angels García-Cazorla, Belén Pérez‐Dueñas, K.M. Gorman, Lorenzo Biassoni, John Cain, Toni S. Pearson, F. Lucy Raymond, Elisenda Cortès-Saladelafont, Deborah Hughes, Rosalind J. Jefferson, Kshitij Mankad, Pichet Termsarasab, and Simon Pope
- Subjects
0301 basic medicine ,Movement disorders ,parkinsonism ,DNAJC6 ,Dopamine ,Auxilin ,Regular Issue Articles ,Bioinformatics ,dopamine ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Parkinsonian Disorders ,Medicine ,Homeostasis ,Humans ,Neurotransmitter ,Child ,Research Articles ,Dystonia ,auxilin ,business.industry ,Parkinsonism ,Neurodegeneration ,Dopaminergic ,dystonia ,HSP40 Heat-Shock Proteins ,medicine.disease ,030104 developmental biology ,Neurology ,chemistry ,Mutation ,Neurology (clinical) ,medicine.symptom ,business ,030217 neurology & neurosurgery ,medicine.drug ,Research Article - Abstract
BACKGROUND: Juvenile forms of parkinsonism are rare conditions with onset of bradykinesia, tremor and rigidity before the age of 21 years. These atypical presentations commonly have a genetic aetiology, highlighting important insights into underlying pathophysiology. Genetic defects may affect key proteins of the endocytic pathway and clathrin-mediated endocytosis (CME), as in DNAJC6-related juvenile parkinsonism. OBJECTIVE: To report on a new patient cohort with juvenile-onset DNAJC6 parkinsonism-dystonia and determine the functional consequences on auxilin and dopamine homeostasis. METHODS: Twenty-five children with juvenile parkinsonism were identified from a research cohort of patients with undiagnosed pediatric movement disorders. Molecular genetic investigations included autozygosity mapping studies and whole-exome sequencing. Patient fibroblasts and CSF were analyzed for auxilin, cyclin G-associated kinase and synaptic proteins. RESULTS: We identified 6 patients harboring previously unreported, homozygous nonsense DNAJC6 mutations. All presented with neurodevelopmental delay in infancy, progressive parkinsonism, and neurological regression in childhood. (123) I-FP-CIT SPECT (DaTScan) was performed in 3 patients and demonstrated reduced or absent tracer uptake in the basal ganglia. CSF neurotransmitter analysis revealed an isolated reduction of homovanillic acid. Auxilin levels were significantly reduced in both patient fibroblasts and CSF. Cyclin G-associated kinase levels in CSF were significantly increased, whereas a number of presynaptic dopaminergic proteins were reduced. CONCLUSIONS: DNAJC6 is an emerging cause of recessive juvenile parkinsonism-dystonia. DNAJC6 encodes the cochaperone protein auxilin, involved in CME of synaptic vesicles. The observed dopamine dyshomeostasis in patients is likely to be multifactorial, secondary to auxilin deficiency and/or neurodegeneration. Increased patient CSF cyclin G-associated kinase, in tandem with reduced auxilin levels, suggests a possible compensatory role of cyclin G-associated kinase, as observed in the auxilin knockout mouse. DNAJC6 parkinsonism-dystonia should be considered as a differential diagnosis for pediatric neurotransmitter disorders associated with low homovanillic acid levels. Future research in elucidating disease pathogenesis will aid the development of better treatments for this pharmacoresistant disorder. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
- Published
- 2020